Epigenetics in Human Development and Diseases

A special issue of Genes (ISSN 2073-4425). This special issue belongs to the section "Molecular Genetics and Genomics".

Deadline for manuscript submissions: 25 March 2025 | Viewed by 139

Special Issue Editors


E-Mail Website
Guest Editor
Centre of Exact and Natural Sciences, Molecular Biology Department, Federal University of Paraíba, Cidade Universitária—Campus I, João Pessoa 58051-900, PB, Brazil
Interests: epigenetic; DNA methylation; oral diseases; multifactorial diseases; genetic
Special Issues, Collections and Topics in MDPI journals

E-Mail Website
Guest Editor
Department of Cell Biology, University Federal of Paraná, Curitiba, PR, Brazil
Interests: genetic; epigenetic; human development and diseases; oral diseases; molecular biology
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

The molecular era has unraveled aspects of epigenetics in development and disease in humans. The great advancements in this area mainly come from data referring to tumor diseases; however, epigenetic aspects of human development and in inflammatory and mental diseases are still neglected in this regard. Epigenetic markers (DNA methylation, RNA methylation, histone modification, and micro-RNAs) can be used as biomarkers and, since they are reversible, they can also be targets for treatments. In addition to genetic studies, the epigenetic approach can contribute to precision medicine, a healthcare model which advocates for the construction of biological databases for each individual based on concepts of classical genetics, epigenetic marks, metabolomics, and aspects of the patient's clinical phenotype, enabling the establishment of more accurate lines of diagnosis and treatment. This is a promising perspective that could be applied for reducing healthcare costs and lessening patient suffering.

The types of manuscripts we are interested in include original research, reviews, mini reviews, and case reports.

Specific themes include:

  1. DNA methylation and RNA methylation marks which are involved in human development and disease;
  2. Histone modification marks including methylation, acetylation, etc., which are involved in human development and disease;
  3. Non-coding RNA expression, including miRNA, lncRNA, etc., which are involved in human development and disease;
  4. Studies with epigenetic drugs will also be considered.

Dr. Naila Francis Paulo De Oliveira
Dr. Maria Cristina Leme Godoy dos Santos
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Genes is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • health development
  • inflammatory diseases
  • mental diseases
  • tumor diseases
  • epigenetic drugs

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

Further information on MDPI's Special Issue polices can be found here.

Published Papers

This special issue is now open for submission, see below for planned papers.

Planned Papers

The below list represents only planned manuscripts. Some of these manuscripts have not been received by the Editorial Office yet. Papers submitted to MDPI journals are subject to peer-review.

1. Title: Can global methylation be influenced by polymorphisms in genes involved in epigenetic mechanisms?
Back to TopTop